| scholarly article | Q13442814 |
| P50 | author | Roberta Gualtierotti | Q40646358 |
| P2093 | author name string | Francesca Ingegnoli | |
| Nicola Ughi | |||
| Giovanni Marfia | |||
| P2860 | cites work | Cardiovascular disease in rheumatoid arthritis | Q86831874 |
| Thromboembolic and cardiovascular risk in rheumatoid arthritis: role of the haemostatic system | Q87109306 | ||
| Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis | Q87248594 | ||
| Adalimumab decreases aortic stiffness independently of its effect in disease activity in patients with rheumatoid arthritis | Q88077426 | ||
| [Summary of the multidisciplinary guideline on cardiovascular risk management (revision 2011)] | Q95406580 | ||
| Mediterranean diet for primary prevention of cardiovascular disease | Q95763689 | ||
| Homocysteine-lowering interventions for preventing cardiovascular events | Q24186605 | ||
| Effect of cyclosporine on blood pressure | Q24240463 | ||
| Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence | Q24685486 | ||
| Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis | Q26859516 | ||
| Progress and challenges in translating the biology of atherosclerosis | Q29619982 | ||
| Rheumatoid arthritis. | Q30244019 | ||
| EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update | Q30244903 | ||
| Cardiovascular Disease in Women: Clinical Perspectives | Q30743765 | ||
| Cardiac involvement in patients with rheumatic disorders: Data of the RHEU-M(A)R study | Q31128332 | ||
| Leflunomide in the treatment of patients with early rheumatoid arthritis--results of a prospective non-interventional study | Q33956623 | ||
| 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by repres | Q34046881 | ||
| Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis | Q34160359 | ||
| Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics | Q34233328 | ||
| Electronic cigarettes for smoking cessation: a randomised controlled trial | Q34370483 | ||
| Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project | Q34534248 | ||
| Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis | Q34547253 | ||
| Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis | Q34648366 | ||
| Coronary microvascular dysfunction: an update | Q34658569 | ||
| Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease | Q34684331 | ||
| The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. | Q35092457 | ||
| The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. | Q35135831 | ||
| Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease | Q35377706 | ||
| The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations | Q35387131 | ||
| An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis | Q35552423 | ||
| Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study | Q35605663 | ||
| Statin use and musculoskeletal pain among adults with and without arthritis | Q35697228 | ||
| Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis | Q35777047 | ||
| The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease | Q35904678 | ||
| Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. | Q36031031 | ||
| Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process | Q36162860 | ||
| Is Lipoprotein-Associated Phospholipase A2 a Link between Inflammation and Subclinical Atherosclerosis in Rheumatoid Arthritis? | Q36172927 | ||
| Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis | Q36702061 | ||
| Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. | Q36738148 | ||
| The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. | Q37074034 | ||
| Association between low density lipoprotein and rheumatoid arthritis genetic factors with low density lipoprotein levels in rheumatoid arthritis and non-rheumatoid arthritis controls | Q37273794 | ||
| Methotrexate: mechanism of action, pharmacokinetics, clinical indications, and toxicity | Q37287439 | ||
| Rheumatoid factors: clinical applications | Q37353700 | ||
| Carotid Artery Atherosclerosis in Patients with Active Rheumatoid Arthritis: Predictors of Plaque Occurrence and Progression Over 24 Weeks. | Q37390580 | ||
| Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions | Q37415092 | ||
| Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. | Q37583248 | ||
| Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis | Q37998219 | ||
| Cardiovascular disease in autoimmune rheumatic diseases. | Q38094402 | ||
| Do statins reduce the cardiovascular risk in patients with rheumatoid arthritis? | Q38220433 | ||
| The impact of statins therapy on disease activity and inflammatory factor in patients with rheumatoid arthritis: a meta-analysis | Q38261237 | ||
| Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functions | Q38293477 | ||
| Decreased Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis (RA) in Recent Years: Dawn of a New Era in Cardiovascular Disease in RA? | Q38401848 | ||
| Prevention of cardiovascular disease in rheumatoid arthritis | Q38539171 | ||
| Cardiovascular comorbidity in rheumatic diseases | Q38568465 | ||
| Coexistence of ischemic heart disease and rheumatoid arthritis patients-A case control study | Q38710725 | ||
| Smoking and Air Pollution as Pro-Inflammatory Triggers for the Development of Rheumatoid Arthritis. | Q38766413 | ||
| Predictive Value of Arterial Stiffness and Subclinical Carotid Atherosclerosis for Cardiovascular Disease in Patients with Rheumatoid Arthritis | Q38852492 | ||
| Echocardiography in the Assessment of Patients with Rheumatologic Diseases | Q38866037 | ||
| Loss of lean body mass affects low bone mineral density in patients with rheumatoid arthritis - results from the TOMORROW study. | Q38984869 | ||
| Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms. | Q39037812 | ||
| An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy | Q39110166 | ||
| Magnetic Resonance Imaging-Detected Myocardial Inflammation and Fibrosis in Rheumatoid Arthritis: Associations With Disease Characteristics and N-Terminal Pro-Brain Natriuretic Peptide Levels | Q39215532 | ||
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update | Q40305889 | ||
| Cardiovascular risk assessment in patients with rheumatoid arthritis: a correlative study of noninvasive arterial health testing | Q40419608 | ||
| Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis | Q40850003 | ||
| Association of homocysteine with immunological-inflammatory and metabolic laboratory markers and factors in relation to hyperhomocysteinaemia in rheumatoid arthritis | Q41031784 | ||
| Interleukin 6 Inhibition and Coronary Artery Disease in a High-Risk Population: A Prospective Community-Based Clinical Study | Q41103987 | ||
| Association of Nocturnal Hypertension With Disease Activity in Rheumatoid Arthritis | Q41550162 | ||
| Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study | Q41728784 | ||
| Arterial stiffness and ankle brachial index in patients with rheumatoid arthritis and inflammatory bowel disease | Q41811014 | ||
| Confounding by indication probably distorts the relationship between steroid use and cardiovascular disease in rheumatoid arthritis: results from a prospective cohort study | Q41901454 | ||
| Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications | Q41921823 | ||
| Prothrombotic biomarkers in patients with rheumatoid arthritis: the beneficial effect of IL-6 receptor blockade | Q42491974 | ||
| Outcomes in patients with rheumatoid arthritis and myocardial infarction. | Q43618212 | ||
| The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients | Q43714093 | ||
| A randomized controlled trial of a cognitive behavioural patient education intervention vs a traditional information leaflet to address the cardiovascular aspects of rheumatoid disease. | Q43826908 | ||
| Antibodies to citrullinated peptides and risk of coronary heart disease | Q43934505 | ||
| Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease | Q44204800 | ||
| The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis | Q44558171 | ||
| Inflammatory burden interacts with conventional cardiovascular risk factors for carotid plaque formation in rheumatoid arthritis | Q44958376 | ||
| Effect of naproxen and acetaminophen on blood pressure lowering by ramipril, valsartan and aliskiren in hypertensive patients | Q45005642 | ||
| The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study | Q45792532 | ||
| Influence of disease activity on the physical activity of rheumatoid arthritis patients. | Q45985880 | ||
| Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. | Q46003173 | ||
| The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011. | Q46559317 | ||
| Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries | Q47817154 | ||
| Ten-year progression of coronary artery, carotid artery, and aortic calcification in patients with rheumatoid arthritis. | Q47878182 | ||
| Individualised exercise improves endothelial function in patients with rheumatoid arthritis. | Q47886360 | ||
| Understanding cardiovascular risk in rheumatoid arthritis: Still a long way to go. | Q53693771 | ||
| Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies. | Q55058901 | ||
| 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis | Q57245378 | ||
| Link between traditional cardiovascular risk factors and inflammation in patients with early arthritis: Results from a French Multicenter Cohort | Q57658287 | ||
| Effects of high-intensity resistance training in patients with rheumatoid arthritis: A randomized controlled trial | Q57915748 | ||
| Potential Effect of Anti-Tumour Necrosis Factor-Alpha Treatment on Reducing the Cardiovascular Risk Related to Rheumatoid Arthritis | Q58418470 | ||
| Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: Effects of tumor necrosis factor-α blockade | Q58418512 | ||
| Arterial hypertension assessed "out-of-office" in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated "white c | Q59303860 | ||
| Investigation and management of heritable thrombophilia | Q74502662 | ||
| Carotid atherosclerosis, disease measures, oxidized low-density lipoproteins, and atheroprotective natural antibodies for cardiovascular disease in early rheumatoid arthritis -- an inception cohort study | Q84141759 | ||
| Anti-tumor necrosis factor alpha therapy normalizes fibrinolysis impairment in patients with active rheumatoid arthritis | Q84252924 | ||
| Tumor necrosis factor α inhibitor use and decreased risk for incident coronary events in rheumatoid arthritis | Q85720945 | ||
| Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study | Q85890944 | ||
| Does reduction of disease activity improve early markers of cardiovascular disease in newly diagnosed rheumatoid arthritis patients? | Q86527062 | ||
| P433 | issue | 2 | |
| P921 | main subject | comorbidity | Q1414874 |
| P304 | page(s) | 293-308 | |
| P577 | publication date | 2017-07-27 | |
| P1433 | published in | Rheumatology and therapy | Q27727370 |
| P1476 | title | Practical Management of Cardiovascular Comorbidities in Rheumatoid Arthritis | |
| P478 | volume | 4 |
Search more.